You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.


( a-bi-RA-te-rone )
Exceptional Access Program
  • abiraterone - Metastatic castrate-resistant prostate cancer, according to specific criteria
Other Name(s): Zytiga®
Appearance: tablet in various colours and strengths

You might also be interested in